LaGray is the first fully-integrated generic pharmaceutical manufacturer in West Africa. We produce both active pharmaceutical ingredients and finished dosage forms.
Our focus is on drugs for treating endemic diseases such as HIV-AIDS, opportunistic infections, malaria, tuberculosis and parasitic, bacterial and fungal infections.
The high burden of disease in sub-Saharan Africa contributes to >70% of the mortality in the region and account for massive economic losses. Although there are currently effective drugs for treating most of these diseases, the issue is affordability and availability.
Your request has been submitted successfully.
Own or work here?
